Fulfilling the Promise of Precision Medicine

As a leading molecular informatics company, Caris Life Sciences® develops and utilizes the most advanced technologies to provide both clinically actionable information and innovative research at the vanguard of medical science. Caris was founded because of an idea – that personalized and precise information can improve healthcare for everyone. Caris combines the analytics of an information company with the rigor of an academic medical institution and the innovation of a technology company. We believe that high quality testing and information can lead to better diagnosis, more effective treatment selection, and ultimately to better outcomes for patients with cancer and other complex diseases.

Caris Molecular Intelligence®, the industry’s leading tumor profiling service with more than 70,000 patients profiled, provides oncologists with the most potentially clinically actionable treatment options available to personalize cancer care today. The company is also developing a series of tests based on its proprietary Carisome® TOP™ platform, a revolutionary blood-based testing technology for diagnosis, prognosis, and theranosis of cancer and other complex diseases.

Headquartered in the Dallas-Fort Worth Metroplex, Caris Life Sciences offers services throughout Europe, the U.S., Australia and other international markets.